Skip to main contentSkip to footer content

About: Next generation biotech company

tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug Tiprelestat.

5 Facts about tiakis

Located in Kiel in the north of Germany

More than 20 years of experience

Lead by a dynamic and multi-disciplinary team

Trusted by renowned partners all over the world

Selected as a partner in federal and state driven R&D programs

“Incorporated in 2000 with full focus on its novel therapy approach“

Our Values: Driven by the vision to improve human health

We seek to shift the treatment paradigm towards a preventive approach that alleviates the suffering and morbidity of most patients undergoing highly invasive surgery by protecting them from inflammatory organ damage and failure.

Prevent

We aim to alleviate and prevent the suffering of patients undergoing highly invasive surgery

Help

We want to improve the quality of life for patients with chronic pulmonary disease such as pulmonary arterial hypertension

Empower

We employ the human body’s own and natural defense mechanisms

Change

We want to treat underlying root causes instead of just the symptoms

Trust

More than 20 years of patient dedicated reliability towards our partners and stakeholders

For quotes regarding the sale of Elafin, please contact our sales team

Become part of the tiakis team

Find our current job offers here